Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Jack YangFredrick S NolteOlga S ChajewskiKathryn G LindseyPatricia M HouserJalidsa PellicierQun WangLaleh EhsaniPublished in: Diagnostic cytopathology (2017)
HR-HPV testing plays an important role in cervical cancer screening by identifying HSIL in patients with ASC-US, LSIL, and NILM. Co-testing is an optimal method to identifying the patients with higher risk for developing cervical abnormalities.